In today’s ever-changing landscape of pharmaceutical R&D, drug development program and portfolio management, portfolio prioritization, capacity management, resource forecasting, risk mitigation, and strategic decision-making are paramount.

Cambridge Healthtech Institute’s Biopharma Strategy Series presents Executive Decision Making for Pharma and Biotech offers a comprehensive platform for high-level discussions, interactive sessions, networking opportunities, breakout roundtables, and personalized 1:1 meetings. Attendees will leave with new tools and organizational strategies to optimize project planning, portfolio insights and decision making; and align resource planning, allocation, and capacity management with portfolio prioritization.

Cerbrec is honored to be exhibiting at Executive Decision Making for Pharma and Biotech 2024, where we will showcase the Cerbrec Graphbook. Our leading Graphical AI platform enables researchers to seamlessly integrate AI models into their experiments through an intuitive point-and-click interface, unlocking new possibilities for scientific discovery and advancement.